Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022029066 - METHOD FOR NASH RISK ASSESSMENT

Publication Number WO/2022/029066
Publication Date 10.02.2022
International Application No. PCT/EP2021/071548
International Filing Date 02.08.2021
IPC
G01N 33/68 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
CPC
G01N 2800/085
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
08Hepato-biliairy disorders other than hepatitis
085Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
G01N 2800/56
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
56Staging of a disease; Further complications associated with the disease
G01N 2800/7052
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
70Mechanisms involved in disease identification
7052Fibrosis
G01N 33/6893
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
6893related to diseases not provided for elsewhere
Applicants
  • GENFIT [FR]/[FR]
Inventors
  • MAJD, Zouher
  • CHAUMAT, Pierre
Agents
  • CABINET BECKER ET ASSOCIES
Priority Data
20305895.303.08.2020EP
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) METHOD FOR NASH RISK ASSESSMENT
(FR) PROCÉDÉ D'ÉVALUATION DU RISQUE DE NASH
Abstract
(EN) The present invention relates to a new assay to diagnose nonalcoholic steatohepatitis (NASH), NASH progression and NASH fibrosis stage.
(FR) La présente invention concerne un nouveau dosage pour diagnostiquer une stéatohépatite non alcoolique (NASH), une progression de NASH et un stade de fibrose de NASH.
Latest bibliographic data on file with the International Bureau